Lu AF28996 in Participants With Parkinson's Disease (PD)
Public ClinicalTrials.gov record NCT04291859. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Interventional, Open-label, Exploratory Study, Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Lu AF28996 in Patients With Parkinson's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to investigate the safety of Lu AF28996, how well it is tolerated and what the body does to the drug in participants with Parkinson's disease.
Study identification
- NCT ID
- NCT04291859
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 57 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 35 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 26, 2020 (Actual)
- Primary completion
- Oct 14, 2025 (Actual)
- Completion
- Feb 12, 2026 (Actual)
- Last update posted
- Mar 6, 2026
2020 – 2026
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CenExel Los Alamitos | Los Alamitos | California | 90720 | — |
| Georgetown University | Washington D.C. | District of Columbia | 20007 | — |
| Velocity | Hallandale | Florida | 33009 | — |
| Parkinson's Disease Treatment Center of SW FL | Port Charlotte | Florida | 33980 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30331 | — |
| Hawaii Pacific Neuroscience | Honolulu | Hawaii | 96817 | — |
| QUEST Research Institute | Farmington Hills | Michigan | 48334 | — |
| Neurology Consultants of Nebraska | Omaha | Nebraska | 68154 | — |
| Inland Nortwest Research | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04291859, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 6, 2026 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04291859 live on ClinicalTrials.gov.